KYMR - Kymera Therapeutics Inc
IEX Last Trade
48.42
0.170 0.351%
Share volume: 622,969
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$48.25
0.17
0.35%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-22 | 2024-05-02 | |
| Total revenue | 11.514 M | 9.551 M | 16.139 M | 9.466 M | 16.513 M | 4.728 M | 47.885 M | 10.287 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 11.514 M | 9.551 M | 16.139 M | 9.466 M | 16.513 M | 4.728 M | 47.885 M | 10.287 M | |
| -17.05% | 68.98% | -41.35% | 74.45% | -71.37% | 912.80% | -78.52% | |||
| Operating expenses | 52.324 M | 54.433 M | 54.770 M | 54.792 M | 59.896 M | 62.237 M | 67.197 M | 63.193 M | |
| Selling general and admin | 11.031 M | 10.556 M | 11.636 M | 12.565 M | 14.129 M | 14.120 M | 14.227 M | 14.374 M | |
| Research and development | 41.293 M | 43.877 M | 43.134 M | 42.227 M | 45.767 M | 48.117 M | 52.970 M | 48.819 M | |
| Total expenses | 52.324 M | 54.433 M | 54.770 M | 54.792 M | 59.896 M | 62.237 M | 67.197 M | 63.193 M | |
| 4.03% | 0.62% | 0.04% | 9.32% | 3.91% | 7.97% | -5.96% | |||
| Operating income | -40.810 M | -44.882 M | -38.631 M | -45.326 M | -43.383 M | -57.509 M | -19.312 M | -52.906 M | |
| Ebit | -40.810 M | -44.882 M | -38.631 M | -45.326 M | -43.383 M | -57.509 M | -19.312 M | -52.906 M | |
| Pretax income | -40.257 M | -43.002 M | -34.865 M | -40.928 M | -38.799 M | -52.867 M | -14.368 M | -48.557 M | |
| 6.82% | -18.92% | 17.39% | -5.20% | 36.26% | -72.82% | 237.95% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -40.257 M | -43.002 M | -34.865 M | -40.928 M | -38.799 M | -52.867 M | -14.368 M | -48.557 M | |
| -6.82% | 18.92% | -17.39% | 5.20% | -36.26% | 72.82% | -237.95% | |||
| Net income | -40.257 M | -43.002 M | -34.865 M | -40.928 M | -38.799 M | -52.867 M | -14.368 M | -48.557 M | |
| -6.82% | 18.92% | -17.39% | 5.20% | -36.26% | 72.82% | -237.95% |